Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 6,417,000 | 5,340,000 | 5,155,000 | 5,178,000 | 5,777,000 |
| Cost of Goods | 1,637,000 | 1,153,000 | 1,012,000 | 1,134,000 | 1,225,000 |
| Gross Profit | 4,780,000 | 4,187,000 | 4,143,000 | 4,044,000 | 4,552,000 |
| Operating Expenses | 4,766,000 | 3,336,000 | 3,380,000 | 3,348,000 | 5,251,000 |
| Operating Income | 14,000 | 851,000 | 763,000 | 696,000 | -699,000 |
| Interest Expense | 284,000 | 364,000 | 375,000 | 343,000 | 161,000 |
| Other Income | 1,000,000 | -10,000 | 24,000 | 21,000 | 1,267,000 |
| Pre-tax Income | 730,000 | 477,000 | 412,000 | 374,000 | 407,000 |
| Income Tax | -279,000 | 71,000 | 93,000 | 58,000 | -854,000 |
| Net Income Continuous | 1,009,000 | 406,000 | 319,000 | 316,000 | 1,261,000 |
| Minority Interests | 25,000 | 25,000 | 31,000 | 24,000 | 40,000 |
| Net Income | $1,034,000 | $431,000 | $350,000 | $340,000 | $1,301,000 |
| EPS Basic Total Ops | 0.82 | 0.34 | 0.27 | 0.27 | 1.03 |
| EPS Basic Continuous Ops | 0.82 | 0.34 | 0.27 | 0.27 | 1.03 |
| EPS Diluted Total Ops | 0.82 | 0.34 | 0.27 | 0.27 | 1.03 |
| EPS Diluted Continuous Ops | 0.82 | 0.34 | 0.27 | 0.27 | 1.03 |
| EBITDA(a) | $2,676,000 | $1,539,000 | $1,471,000 | $1,426,000 | $1,675,000 |